Experienced in Acid Sphingomyelinase Deficiency (ASMD)

Zoltan Z. Nagy

Mária Str. 39, 
Budapest, BU, HU 
Experienced in Acid Sphingomyelinase Deficiency (ASMD)
Mária Str. 39, 
Budapest, BU, HU 
OverviewLocationsClinical Research

Overview

Zoltan Nagy practices in Budapest, Hungary. Mr. Nagy is rated as an Experienced expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). His top areas of expertise are Aniridia, Cataract, Diabetic Retinopathy, Cataract Removal, and Vitrectomy.

His clinical research consists of co-authoring 286 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acid Sphingomyelinase Deficiency (ASMD).

Gender
Male

Locations

Mária Str. 39, Budapest, BU 1085, Hungary
Other Locations
26 Üllői Street, Budapest, BU 1085, Hungary

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective Single Center Clinical Study for Femtosecond Laser Glaucoma Surgery Using the ViaLase Laser
A Prospective Single Center Clinical Study for Femtosecond Laser Glaucoma Surgery Using the ViaLase Laser
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Study to Compare Clinical Outcomes of Hydrophobic Trifocal IOLs FineVision POD F GF and FineVision POD L GF After Bilateral Implantation
Clinical Study to Compare Clinical Outcomes of Hydrophobic Trifocal IOLs FineVision POD F GF and FineVision POD L GF After Bilateral Implantation
Enrollment Status: Completed
Publish Date: January 11, 2022
Intervention Type: Device
Study Phase: Not Applicable
Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)
Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)
Enrollment Status: Completed
Publish Date: May 06, 2021
Intervention Type: Device
Study Phase: Not Applicable
PRevention of Macular EDema After Cataract Surgery
PRevention of Macular EDema After Cataract Surgery
Enrollment Status: Completed
Publish Date: April 14, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

286 Total Publications

N,N-dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation.
N,N-dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation.
Journal: Science advances
Published: August 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nagy's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 72 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile